These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. HMGA1 promotes the progression of esophageal squamous cell carcinoma by elevating TKT-mediated upregulation of pentose phosphate pathway. Liu MJ, Zhao Y, Li QT, Lei XY, He KY, Guo JR, Yang JY, Yan ZH, Wu DH, Zhang L, Jian YP, Xu ZX. Cell Death Dis; 2024 Jul 30; 15(7):541. PubMed ID: 39080260 [Abstract] [Full Text] [Related]
4. IQGAP1 overexpression attenuates chemosensitivity through YAP-mediated ferroptosis inhibition in esophageal squamous cell cancer cells. Li X, Zhao X, Su X, Wen J, Yang S, Qin Y, Yan S, Yao Y, Li X, Wang X. Arch Biochem Biophys; 2024 Aug 30; 758():110064. PubMed ID: 38897534 [Abstract] [Full Text] [Related]
12. LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2. Zhang Z, Xiong R, Li C, Xu M, Guo M. Acta Biochim Biophys Sin (Shanghai); 2019 Aug 05; 51(8):826-833. PubMed ID: 31287493 [Abstract] [Full Text] [Related]
13. CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas. Fang J, Ma Y, Li Y, Li J, Zhang X, Han X, Ma S, Guan F. Mol Carcinog; 2022 Nov 05; 61(11):1043-1055. PubMed ID: 36102200 [Abstract] [Full Text] [Related]
20. A novel link between circPDE3B and ferroptosis in esophageal squamous cell carcinoma progression. Zhou P, Wu Z, Zhang Q, Wang L, Zhang W, Han X. Genomics; 2024 Jan 05; 116(1):110761. PubMed ID: 38092323 [Abstract] [Full Text] [Related] Page: [Next] [New Search]